Schloemer JH , Zagozen JJ: Cost analysis of an aminoglycoside pharmacokinetic dosing program. Am J Hosp Pharm41:2347-2351, 1984
2.
Kimelblatt BJ , Bradbury K., Chodoff L., et al: Cost-benefit analysis of an aminoglycoside monitoring service. Am J Hosp Pharm43:1205-1209, 1986
3.
Smith M., Murphy JE, Job ML, et al: Aminoglycoside monitoring: Use of a pharmacokinetic service versus physician recommendations. Hosp Formul22:92-102, 1987
4.
Crist KD, Nahata MC, Ety J.: Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization. Ther Drug Monit9:306-310, 1987
5.
Destache.CJ, Meyer SK, Padomek MT, et al: Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides for gram-negative infections. DICP23:33-38,1989
6.
Anon: Directions for clinical practice in pharmacy. Am J Hosp Pharm42:1287-1342, 1985
7.
Hepler CD: Economic aspects of clinical decision making: Evaluating clinical programs . Am J Hosp Pharm45:554-560,1988
8.
Moore RD, Smith CR, Lietman PS: The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis2:443-448, 1984
9.
Moore RD, Smith CR, Lietman PS: Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med77:657-662,1984
10.
Polk RE, Markowitz SM, Mayhall CG: Aminoglycoside predictions using a hand held calculator: Limitations of the model. Drug Intell Clin Pharm15:751-757, 1981
11.
Rodvold KA, Zokufa H., Rotschafer JC: Aminoglycoside pharmacokinetic monitoring: An integral part of patient care?Clin Pharm7:608-613, 1988
12.
Fant WK: Controversies in antimicrobial therapy: Pitfalls in monitoring aminoglycoside therapy. Am J Hosp Pharm43:641-646, 1986
13.
Boyce EG, Pugh CB: Computer-simulated effect of errors in infusion duration and blood sampling times on pharmacokinetic calculations for gentamicin. Clin Pharm8:48-53, 1989
14.
Sawchuk RJ, Zaske DE: Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients. J Pharmacokinet Biopharm4:183-195, 1976
15.
Torres MJ, Kern JW, Gill MA, et al: Comparison of serum sampling methods for estimating gentamicin pharmacokinetic variables. Clin Pharm2:353-355, 1983
16.
Chiou WL: A simple and accurate midpoint-back-extrapolation method for pharmacokinetic individualization of aminoglycoside therapy. Ther Drug Monit10:237-238, 1988